These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 9428657
1. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase. Perola E, Cellai L, Lamba D, Filocamo L, Brufani M. Biochim Biophys Acta; 1997 Nov 14; 1343(1):41-50. PubMed ID: 9428657 [Abstract] [Full Text] [Related]
2. Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia. Brufani M, Marta M, Pomponi M. Eur J Biochem; 1986 May 15; 157(1):115-20. PubMed ID: 3709528 [Abstract] [Full Text] [Related]
11. Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds. Brossi A, Schönenberger B, Clark OE, Ray R. FEBS Lett; 1986 Jun 09; 201(2):190-2. PubMed ID: 3709808 [Abstract] [Full Text] [Related]
13. Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL). Moriearty PL, Becker RE. Methods Find Exp Clin Pharmacol; 1992 Oct 09; 14(8):615-21. PubMed ID: 1494302 [Abstract] [Full Text] [Related]
14. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. Braida D, Sala M. CNS Drug Rev; 2001 Oct 09; 7(4):369-86. PubMed ID: 11830755 [Abstract] [Full Text] [Related]
15. Effects of hexamethonium, phenothiazines, propranolol and ephedrine on acetylcholinesterase carbamylation by physostigmine, aldicarb and carbaryl: interaction between the active site and the functionally distinct peripheral sites in acetylcholinesterase. Singh AK, Spassova D. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Jan 09; 119(1):97-105. PubMed ID: 9568379 [Abstract] [Full Text] [Related]
16. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J. Drugs Aging; 2004 Jan 09; 21(7):453-78. PubMed ID: 15132713 [Abstract] [Full Text] [Related]
17. Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease. Li Y, Zhang XX, Jiang LJ, Yuan L, Cao TT, Li X, Dong L, Li Y, Yin SF. Chem Biol Drug Des; 2015 Oct 09; 86(4):776-82. PubMed ID: 25736722 [Abstract] [Full Text] [Related]
18. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease. Greig NH, Pei XF, Soncrant TT, Ingram DK, Brossi A. Med Res Rev; 1995 Jan 09; 15(1):3-31. PubMed ID: 7898167 [No Abstract] [Full Text] [Related]
19. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Rakonczay Z. Acta Biol Hung; 2003 Jan 09; 54(2):183-9. PubMed ID: 14535624 [Abstract] [Full Text] [Related]
20. Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain. Gavuzzo E, Pomponi M. J Biochem Mol Toxicol; 2002 Jan 09; 16(2):64-9. PubMed ID: 11979423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]